ES2112271T3 - Uso del factor-4 de plaqueta (pf4) o fragmentos del mismo en la fabricacion de medicamentos para la neutralizacion de la heparina. - Google Patents

Uso del factor-4 de plaqueta (pf4) o fragmentos del mismo en la fabricacion de medicamentos para la neutralizacion de la heparina.

Info

Publication number
ES2112271T3
ES2112271T3 ES91905244T ES91905244T ES2112271T3 ES 2112271 T3 ES2112271 T3 ES 2112271T3 ES 91905244 T ES91905244 T ES 91905244T ES 91905244 T ES91905244 T ES 91905244T ES 2112271 T3 ES2112271 T3 ES 2112271T3
Authority
ES
Spain
Prior art keywords
heparin
medicines
neutralization
fragments
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905244T
Other languages
English (en)
Spanish (es)
Inventor
Jacquelynn J Cook
Stefan Niewarowski
Theodore E Maione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Application granted granted Critical
Publication of ES2112271T3 publication Critical patent/ES2112271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES91905244T 1990-02-16 1991-02-14 Uso del factor-4 de plaqueta (pf4) o fragmentos del mismo en la fabricacion de medicamentos para la neutralizacion de la heparina. Expired - Lifetime ES2112271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48087390A 1990-02-16 1990-02-16

Publications (1)

Publication Number Publication Date
ES2112271T3 true ES2112271T3 (es) 1998-04-01

Family

ID=23909691

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905244T Expired - Lifetime ES2112271T3 (es) 1990-02-16 1991-02-14 Uso del factor-4 de plaqueta (pf4) o fragmentos del mismo en la fabricacion de medicamentos para la neutralizacion de la heparina.

Country Status (9)

Country Link
EP (1) EP0515550B1 (de)
JP (1) JPH05505602A (de)
AT (1) ATE161183T1 (de)
CA (1) CA2075957A1 (de)
DE (1) DE69128465T2 (de)
DK (1) DK0515550T3 (de)
ES (1) ES2112271T3 (de)
GR (1) GR3025878T3 (de)
WO (1) WO1991012017A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
WO1998038214A1 (en) * 1997-02-28 1998-09-03 The Texas A & M University System Heparan sulfate/heparin interacting protein compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses

Also Published As

Publication number Publication date
DE69128465D1 (de) 1998-01-29
ATE161183T1 (de) 1998-01-15
WO1991012017A1 (en) 1991-08-22
CA2075957A1 (en) 1991-08-17
EP0515550B1 (de) 1997-12-17
DE69128465T2 (de) 1998-04-16
JPH05505602A (ja) 1993-08-19
EP0515550A4 (en) 1993-06-30
GR3025878T3 (en) 1998-04-30
DK0515550T3 (da) 1998-02-02
EP0515550A1 (de) 1992-12-02

Similar Documents

Publication Publication Date Title
IT8322630A0 (it) Preparato di medicamento per migliorare i sintomi del cancro.
IT1134736B (it) Sorgente di luce incapsulata con guida di fibra accoppiata
BR9202740A (pt) Composicao para o cudado de tecidos
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
ES2061307T3 (es) Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.
IT9067941A0 (it) orientamento del fascio
PT83080B (pt) Processo para a preparacao de compostos biciclicos, de naftiridina ou seus analogos, e dos seus sais, solvatos, hidratos e esteres
BR8804161A (pt) Composicao aperfeicoada esterilizavel por radiacao
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
PT100914A (pt) Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
ES2128348T3 (es) Obtencion de composiciones para el tratamiento de alteraciones de la proliferacion celular.
ES2112271T3 (es) Uso del factor-4 de plaqueta (pf4) o fragmentos del mismo en la fabricacion de medicamentos para la neutralizacion de la heparina.
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
BR8403616A (pt) Artigo esterilizado e estabilizador por radiacao e processo para sua preparacao,artigo flexivel,processo para esterilizar e estabilizar por radiacao uma poliolefina
BR9007070A (pt) Vacina para o tratamento preventivo de infeccao por vermes trematoides do figado em ruminantes
IT1168778B (it) Impiego di derivati dello zucchero per la profilassi e terapia di infezioni da virus e preparati farmaceutici che contengono tali composti
ES519701A0 (es) Procedimiento para la preparacion de derivados de pantenol.
IT1163107B (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
BR8102386A (pt) Aperfeicoamento em processo de cura de borracha insaturada
ES2053499T3 (es) Uso del stomatostatin en la fabricacion de un medicamento para el tratamiento de la artritis reumatoide.
SE8802040D0 (sv) New use
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
BR8305551A (pt) Dispositivo para o tratamento de produtos em panos
MX9201665A (es) Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
BR8303702A (pt) Composicoes pesticidas para o tratamento da madeira

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 515550

Country of ref document: ES